Article Details
Retrieved on: 2024-09-03 17:16:38
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(NASDAQ:IVVD), a biopharmaceutical company, announced today that its investigational monoclonal antibody, PEMGARDA™ (pemivibart), retains neutralizing ...
Article found on: uk.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here